Get started
Author

Annalise Hilts

Observed names: Hilts A, Hilts, Annalise
OpenAlex ID: A5000027607
Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer
2022 · Julie Vanderpoel, Andrea L. Stevens, et al. · Journal of Medical Economics · 47
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices
2023 · Brandon S. Sheffield, Kiefer Eaton, et al. · Current Oncology · 39
PDF
Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
2023 · Timothy Fitzgerald, Maryia Zhdanava, et al. · Dermatology and Therapy · 23
PDF
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer
2024 · Christine M. Bestvina, Dexter Waters, et al. · Journal of Medical Economics · 17
PDF
Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke
2022 · Anna Narezkina, Nausheen Akhter, et al. · Clinical Lymphoma Myeloma & Leukemia · 17
Likelihood of Antimicrobial Resistance in Urinary E. coli Isolates Among US Female Patients with Recurrent Versus Non-Recurrent uUTI
2024 · Debra L. Fromer, Wendy Y. Cheng, et al. · Urology · 12
PDF
Pre-Exposure Prophylaxis for the Prevention of HIV-1: An Assessment of Oral Pre-Exposure Prophylaxis Usage Patterns, First Evidence of HIV-1, and HIV-1 Risk Factors in the United States
2024 · Alan Oglesby, Guillaume Germain, et al. · AIDS Patient Care and STDs · 5
PDF
Impact of next-generation sequencing vs polymerase chain reaction testing on payer costs and clinical outcomes throughout the treatment journeys of patients with metastatic non–small cell lung cancer
2024 · Christine M. Bestvina, Dexter Waters, et al. · Journal of Managed Care & Specialty Pharmacy · 5
PDF
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer
2024 · Mehmet A Bilen, Ibrahim Khilfeh, et al. · The Oncologist · 5
PDF
Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
2025 · David Waterhouse, Iris Lin, et al. · Journal of health economics and outcomes research · 4
Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data
2024 · Sikander Ailawadhi, Mu Cheng, et al. · Current Problems in Cancer · 4
Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
2023 · Xiaoxiao Lu, Bruno Emond, et al. · Current Medical Research and Opinion · 4
PDF
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction (PCR) versus next-generation sequencing (NGS) testing strategies in metastatic non-small cell lung cancer (mNSCLC).
2023 · Christine M. Bestvina, Dexter Waters, et al. · Journal of Clinical Oncology · 4
PDF
Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race
2024 · Mehmet Bilen, Ibrahim Khilfeh, et al. · ClinicoEconomics and Outcomes Research · 3
Time-to-next treatment (TTNT) and overall survival (OS) among homologous recombination repair (HRR) positive and HRR negative patients with metastatic castration-resistant prostate cancer (mCRPC) initiating first-line (1L) therapy.
2023 · Mehmet Asim Bilen, Ibrahim Khilfeh, et al. · Journal of Clinical Oncology · 2
PDF
Real-World Persistence and Time to Next Treatment with Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke
2021 · Anna Narezkina, Xiaoxiao Lu, et al. · Blood · 2
853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
2021 · Alan Oglesby, Guillaume Germain, et al. · Open Forum Infectious Diseases · 2
Associations Between Social Determinants of Health and Adherence to Biologic Therapies in Patients with Severe Asthma: Real-World Evidence from a Large US Claims Analysis
2026 · Justin Kwiatek, Arijita Deb, et al. · Journal of Asthma and Allergy · 1
PDF
Retrospective Cohort Study of Elderly Users of Single- or Multiple-Inhaler Triple Therapy for the Treatment of Asthma in the USA
2025 · Russell A. Settipane, Guillaume Germain, et al. · Pulmonary Therapy · 1
PDF
Real-world treatment patterns in patients with BRCA 1/2-positive (BRCA+) metastatic castration-resistant prostate cancer (mCRPC) initiating first-line (1L) therapy.
2024 · Mehmet Asim Bilen, Ibrahim Khilfeh, et al. · Journal of Clinical Oncology · 1
HSR22-153: Real-World Time to Discontinuation of First-Line Venetoclax + Obinutuzumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
2022 · Xiaoxiao Lu, Qing Huang, et al. · Journal of the National Comprehensive Cancer Network · 1
Mepolizumab reduces systemic corticosteroid-related toxicities and healthcare burden in patients with eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a retrospective database study
2026 · Thanai Pongdee, Jared Silver, et al. · Frontiers in Allergy
PDF
Associations Between Social Determinants of Health and Adherence to Biologic Therapies in Patients with Severe Asthma: Real-World Evidence from a Large US Claims Analysis
2026 · Kwiatek J, Deb A, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
1544. HIV Following Oral Pre-Exposure Prophylaxis (PrEP) Initiation
2023 · Aimee A Metzner, Guillaume Germain, et al. · Open Forum Infectious Diseases
PDF
CLL-390 Persistence and Time to Next Treatment With Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke: A Real-World Study
2022 · Anna Narezkina, Nausheen Akhter, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 30
Citation count: 199
H-index: 6
I10-index: 6
Year
Topic
Type